New migraine prevention pill EVO756 enters Mid-Stage trial
NCT ID NCT07616128
First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 5 times
Summary
This Phase 2 study tests whether a daily pill called EVO756 can prevent migraines in adults who have not had success with other preventive treatments. About 330 participants will receive either EVO756 or a placebo, and researchers will track how many migraine days they have each month. The goal is to see if EVO756 safely reduces migraine frequency.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- EVO756 (daily oral pill)
- What this could lead to
- If it works, this could offer a new daily pill to prevent migraines for people who haven't had success with other treatments.
- What could go wrong
- This is an early Phase 2 trial with only 330 people, so results may not hold up in larger studies. The drug may not reduce migraines better than a placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Site-Decatur-Alcanza
RECRUITINGDecatur, Georgia, 30030, United States
-
Apple Medical Research Group, Inc
RECRUITINGMiami, Florida, 331216, United States
Contact Email: •••••@•••••
-
Asheville Neurology Specialists, Pa
RECRUITINGAsheville, North Carolina, 28806, United States
-
Bio Behavoural health
RECRUITINGToms River, New Jersey, 08755, United States
-
CA Medical Clinic for Headache
RECRUITINGLos Angeles, California, 90067, United States
-
Clinical Neuroscience Solutions, Inc.
RECRUITINGJacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions, Inc.
RECRUITINGOrlando, Florida, 32819, United States
Contact Email: •••••@•••••
-
Clinical Trials of South Carolina
RECRUITINGCharleston, South Carolina, 29406, United States
Contact Email: •••••@•••••
-
Clinosis - Dent Neurologic Instite
RECRUITINGAmherst, New York, 14226, United States
-
Diablo Clinical Research dba Flourish Research
RECRUITINGWalnut Creek, California, 94598, United States
-
Eximia Research NC
RECRUITINGRaleigh, North Carolina, 27607, United States
-
FutureSearch Trials of Dallas
RECRUITINGDallas, Texas, 75251, United States
-
FutureSearch Trials of Neurology
RECRUITINGAustin, Texas, 78731, United States
Contact Email: •••••@•••••
-
Michigan Headache and Neurological Institute
RECRUITINGAnn Arbor, Michigan, 48104, United States
-
Neuro Pain Research Center
RECRUITINGFresno, California, 93710, United States
-
New England Institute for Neurology and Headache
RECRUITINGStamford, Connecticut, 06905, United States
-
SFF Medical Research Group LLC
RECRUITINGHouston, Texas, 77018, United States
-
Trialsphere Corp
RECRUITINGChandler, Arizona, 85286, United States
Contact Email: •••••@•••••
-
Vantage Clinical Trials
NOT_YET_RECRUITINGTampa, Florida, 33614, United States
-
Vaught Neurological Services
RECRUITINGCrab Orchard, West Virginia, 25827, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?